About conolidine

Andy Chevigné and his crew, RTI-5152-12 is postulated to enhance the levels of opioid peptides that bind to classical opioid receptors while in the brain, leading to heightened painkilling activity. The LIH-RTI study groups established a collaboration settlement and filed a joint patent s
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15